Mycophenolate Mofetil In Autoimmune Hepatitis Patients With Suboptimal Outcomes To Standard Therapy: The Tapestry Study

The outcomes of mycophenolate mofetil (MMF) as rescue therapy for AIH patients who have a suboptimal outcome to standard therapy remain unclear. We evaluated the efficacy and safety of MMF in patients who had failed or were intolerant to corticosteroids with/without azathioprine.

http://ift.tt/2kRLiPa